DK0528903T3 - Fremgangsmåde til forebyggelse af virusreplikation - Google Patents

Fremgangsmåde til forebyggelse af virusreplikation

Info

Publication number
DK0528903T3
DK0528903T3 DK91909315.3T DK91909315T DK0528903T3 DK 0528903 T3 DK0528903 T3 DK 0528903T3 DK 91909315 T DK91909315 T DK 91909315T DK 0528903 T3 DK0528903 T3 DK 0528903T3
Authority
DK
Denmark
Prior art keywords
virus replication
preventing virus
replication
viral
mutation
Prior art date
Application number
DK91909315.3T
Other languages
Danish (da)
English (en)
Inventor
Jack R Wands
Tsanyang Liang
Eithan Galun
Hubert E Blum
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24034871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0528903(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of DK0528903T3 publication Critical patent/DK0528903T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10161—Methods of inactivation or attenuation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cookers (AREA)
  • Cold Cathode And The Manufacture (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Enzymes And Modification Thereof (AREA)
DK91909315.3T 1990-04-20 1991-04-22 Fremgangsmåde til forebyggelse af virusreplikation DK0528903T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51142890A 1990-04-20 1990-04-20

Publications (1)

Publication Number Publication Date
DK0528903T3 true DK0528903T3 (da) 1996-09-30

Family

ID=24034871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909315.3T DK0528903T3 (da) 1990-04-20 1991-04-22 Fremgangsmåde til forebyggelse af virusreplikation

Country Status (10)

Country Link
EP (1) EP0528903B1 (de)
JP (1) JPH05506993A (de)
AT (1) ATE142690T1 (de)
AU (1) AU656136B2 (de)
CA (1) CA2081022A1 (de)
DE (1) DE69122098T2 (de)
DK (1) DK0528903T3 (de)
ES (1) ES2091928T3 (de)
GR (1) GR3021656T3 (de)
WO (1) WO1991016420A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633449A (en) * 1990-03-12 1997-05-27 Cornell Research Foundation, Inc. Induction of resistance to viral diseases in plants
US5596132A (en) * 1990-03-12 1997-01-21 Cornell Research Foundation, Inc. Induction of resistance to virus diseases by transformation of plants with a portion of a plant virus genome involving a read-through replicase gene
US5610050A (en) * 1990-04-20 1997-03-11 The General Hospital Corporation Methods of preventing viral replication
GB9208545D0 (en) * 1992-04-21 1992-06-03 Gatsby Charitable Foundation T Virus resistant plants
WO1993025068A1 (en) * 1992-06-08 1993-12-23 Cornell Research Foundation, Inc. Viral resistance by plant transformation with a replicase portion of a plant virus genome
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
US5683873A (en) * 1995-01-13 1997-11-04 Innovir Laboratories, Inc. EGS-mediated inactivation of target RNA
US6057153A (en) * 1995-01-13 2000-05-02 Yale University Stabilized external guide sequences
DE19517532C2 (de) 1995-05-12 1999-10-28 Max Planck Gesellschaft HBV-Vektoren und Zellen zu ihrer Bereitstellung
CN100412190C (zh) * 2001-03-15 2008-08-20 复旦大学 乙肝病毒全基因组多聚酶嵌合体的组建方法和应用
CN102643858B (zh) * 2011-02-16 2014-04-02 复旦大学 一种高效复制的人乙型肝炎病毒重组载体及其应用
EP3505528B1 (de) 2011-04-21 2020-11-25 Ionis Pharmaceuticals, Inc. Modulation einer hepatitis-b-virus (hbv)-expression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650756T2 (de) * 1985-03-21 2001-10-04 Cornell Res Foundation Inc Vom parasit abgeleiteter widerstand
AU4315689A (en) * 1988-08-16 1990-03-23 Fox Chase Cancer Center Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders
NZ244820A (en) * 1991-10-25 1994-01-26 Isis Pharmaceuticals Inc Oligonucleotide inhibitor of epstein-barr virus.

Also Published As

Publication number Publication date
WO1991016420A1 (en) 1991-10-31
DE69122098T2 (de) 1997-02-20
GR3021656T3 (en) 1997-02-28
DE69122098D1 (de) 1996-10-17
CA2081022A1 (en) 1991-10-21
ATE142690T1 (de) 1996-09-15
AU656136B2 (en) 1995-01-27
JPH05506993A (ja) 1993-10-14
EP0528903B1 (de) 1996-09-11
AU7785891A (en) 1991-11-11
EP0528903A1 (de) 1993-03-03
EP0528903A4 (en) 1993-09-08
ES2091928T3 (es) 1996-11-16

Similar Documents

Publication Publication Date Title
DK0528903T3 (da) Fremgangsmåde til forebyggelse af virusreplikation
DE69626393T2 (de) Spezifische oligonukleotide für hepatitis b virus
DK156688D0 (da) Praeparat til behandling af virusinfektioner
NO20100145L (no) Forbindelser med serin-protease-inhiberende virkning, spesielt hepatitt C-NS3-inhiberende virkning
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
NO963860L (no) Isoprenyl-transferase-inhibitorer
SE8405133D0 (sv) Anti-viralt medel
NO20026001L (no) 3'-promedikamenter av 2'-deoksy-<Beta>-L-nukleosider
YU46343B (sh) Dna transfer vektor, i postupak za dobijanje vakcine protiv virusa hepatitisa b
DE69434931D1 (de) Methode zur selektiven inaktivierung der viralen replication
DE3750422T2 (de) Translation von mrna.
ATE2014T1 (de) Lebendes, attenuiertes virus des hepatitis a beim menschen, verfahren zu seiner zuechtung in zellkultur in vitro und dieses virus enthaltende zusammensetzung.
DE69122248D1 (de) Hemmung einer virusinfektion
SE8703225L (sv) Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner
DK0497816T3 (da) Behandling af HIV-infektioner og forbindelser anvendelige derved
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
ATE173466T1 (de) Verbindungen und methoden zur inhibition von hiv und verwandten viren
ES2148164T3 (es) Cepa atenuada de vacuna del virus del sarampion, que contiene una secuencia nucleotidica especifica y procedimiento para su identificacion.
DE3765137D1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von virus-infektionen.
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
DK8789D0 (da) Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse
WO1996039500A3 (en) Oligonucleotides specific for hepatitis c virus
HUT44439A (en) Process for inhibiting the reproduction of viruses and virus infections
ATE132527T1 (de) Nicht-zurückmutierende rna-viren
FR2702490B1 (fr) Procédé de lyophilisation de cultures de microorganismes, lyophilisats obtenus et leur utilisation.